Med BioGene (MBGI) Files $24.25M IPO

December 29, 2009 10:22 AM EST
Get Alerts MBGI Hot Sheet
Trade MBGI Now!
Join SI Premium – FREE
Med BioGene, Inc. (NASDAQ: MBGI) filed a registration statement with the SEC for an initial public offering of its common stock. The proposed maximum aggregate offering price is $24.25 million. The company plans to list on the NASDAQ Capital Market under the stock symbol "MBGI."

The offering is being made through Rodman & Renshaw.

Med BioGene is a life science company focused on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer.

You May Also Be Interested In

Related Categories


Related Entities

Rodman & Renshaw

Add Your Comment